authors veeva-systems 
pharmaphorum
DECEMBER 23, 2022
With these silos breaking down, biopharmas will have the opportunity to drive a more coordinated approach to HCP engagement using shared data and unified systems, while still maintaining compliance. Dynamic digital content will drive MLR, health authority collaboration.
pharmaphorum
OCTOBER 19, 2022
Emma Hyland, VP strategy, commercial content at Veeva Systems, tells us modular content is the most significant wave of innovation hitting the content world in life sciences, and rightly so because HCPs’ needs and expectations have changed. We don’t have newer people to manage that within companies, so modular content has to.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
European Pharmaceutical Review
JANUARY 12, 2024
Prior to joining Clarivate, Levy held several roles in the pharmaceutical industry, including at Veeva Systems, Pharmaceutical Product Development (PPD) and Accenture. In the regulatory space, Levy explains that AI/ML is already used to pre-populate submissions to the authorities, for example, by pre-filling set fields.
pharmaphorum
MAY 18, 2021
Pre-commercial companies need to hit the ground running with their launch strategies to be successful,” says Ian Hale, vice president of commercial content at Veeva. Likewise, starting with an integrated multichannel CRM system doesn’t require more resources but ensures alignment and consistency across the commercial operations as they grow.
pharmaphorum
NOVEMBER 18, 2022
Karl Goossens, director of commercial analytics at Veeva Systems Europe, recently spoke with pharmaphorum, discussing how effective omnichannel execution drives revenue and productivity. About the author. He joined Veeva from McKinsey’s QuantumBlack.
pharmaphorum
JANUARY 6, 2023
Chris Moore, president, Veeva Europe, predicts that “in 2023, successful companies will be more deliberate in how they access, manage, and learn from data ahead of a product launch. In 2023, more companies will focus on developing the systems, infrastructure, and skill sets required to work with data-based submissions.
pharmaphorum
OCTOBER 15, 2020
The coronavirus pandemic has forced a traditionally risk-averse industry tied to legacy systems for regulation and compliance to fully embrace digital solutions in commercial and marketing functions. About the author. Bhupinder McJennett, AbbVie. The post Accelerating the digital approval process appeared first on.
Expert insights. Personalized for you.
101 
Let's personalize your content